| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.1 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.079 | 0.1 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.07 | 0.1 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |